期刊文献+

姜黄素-聚维酮固体分散体的制备及溶出度的测定 被引量:22

Study on preparation and in vitro dissolution of curcumin-plasdone solid dispersion
在线阅读 下载PDF
导出
摘要 目的:制备姜黄素-聚维酮固体分散体,改善姜黄素的溶出度。方法:应用聚乙烯吡咯烷酮(PVPk30)为载体,以溶剂法制备固体分散体,差示扫描量热法、X-射线粉末衍射进行物相鉴定,并测定溶出度。结果:姜黄素在固体分散体中可能以无定型态或分子状态存在,药物的累积溶出百分率随载体比例增加而增加,以1∶6的比例效果最好。制成固体分散体后,药物在水中的溶解度达66.28g.L-1。结论:采用PVPk30制备的固体分散体能显著提高姜黄素的溶出度。 OBJECTIVE To prepare solid dispersion for increasing the dissolution of curcumin. METHODS Using polyvinyl pyrrolidone (PVPk30) as the carrier, solid dispersion was prepared by solvent evaporation method. The differential scanning calorimeter(DSC) and powder X-ray diffractometry (PXRD) were used to identify the state of the drug existence in the solid dispersion. The in vitro dissolution characteristics were studied in artificial gastric juice. RESULTS Curcumin existed as amor phous or molecular state in the solid dispersion. The in vitro dissolution rates of curcumin from all solid dispersions were larger than the pure drug and higher carrie-Curcumin ratio led to faster drug dissolution. The solubility of curcumin was improved by the solid dispersion and reached 66. 28 g·L^-1 in water. CONCLUSION The solid dispersion prepared with PVP could increase the dissolution of curcumin.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第21期1819-1822,共4页 Chinese Journal of Hospital Pharmacy
基金 福建省重大专项前期研究项目(编号:2005YZ1010)
关键词 姜黄素 固体分散体 聚乙烯吡咯烷酮 溶出度 curcumin solid dispersion polyvinyl pyrrolidone dissolution
  • 相关文献

参考文献5

二级参考文献33

  • 1孙淑英 蔡玉珉 冷晓红 等.联苯双酯的共沉淀物和固体分散物的制备及其对湿度的稳定性[J].沈阳药学院学报,1987,4(2):99-101.
  • 2Wang YJ, Pan MH, Cheng AL et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharmaceu & Biomed Analysis, 1997 ; 15 (12) : 1867-76.
  • 3Oetari S, Sudibyo M, Commandeur Jan NM et al, Effects of curcumin on cytochrome p450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol, 1996,51(1) : 39-45.
  • 4Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol, 1978;43(2) :86-92.
  • 5Holder GM, Plummer JL, Ryan AJ. The metabolism and excretion of curcumin ( 1,7-his-( 4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica, 1978;8(12):761-8.
  • 6Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Tozicology, 1980;16 (3): 25965.
  • 7Ravindranath V, Chandrasekhara N. Metabolism of curcuminstudies with [^3 H]curcumin. Toxicology, 1982; 22 : 337 - 44.
  • 8Ravindranath V, Chandrasekhara N. In Vitro studies on the intestinal absorption of curcumin in rats. Toxicology, 1981;20(2-3): 251-7.
  • 9Shoba G, Joy D, Joseph T et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.Planta Medica , 1998;64:353-6.
  • 10Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolitism & Disposition, 1999;27(4) :486-94.

共引文献154

同被引文献308

引证文献22

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部